| Developers: | Avasa |
| Date of the premiere of the system: | August 2025 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
Content |
History
2025: Product Announcement
In late August 2025, Avasa, based in Auckland in New Zealand, unveiled a specialist device called the Avasa Coupler for reconstructive microsurgery. This solution provides a safe and fast connection of small arteries.
Avasa notes that the traditional procedure for connecting microarteries requires surgeons to manually stitch them under a microscope: it is a complex and lengthy process with certain risks. The Avasa Coupler eliminates existing complications by making microsurgery safer, faster and more accessible.
The novelty provides the possibility of connecting both arteries and veins during reconstructive microsurgery. According to the developer, the execution time of the corresponding procedures is reduced by 80% compared to the traditional approach. Improving the efficiency of the vascular junction reduces the number of failed surgeries and readmissions. In general, through Avasa Coupler, the company hopes to establish a standard in the field of microvascular compounds.
At the same time, Avasa announced a $2.8 million pre-Series A funding round. The investment program was led by Movac - one of New Zealand's largest and oldest venture capital funds. In addition, existing investor Bridgewest Ventures, who led the seed round, took part in the round. The funds received are expected to help commercialize the Avasa Coupler device.
 | This is a huge milestone for Avasa. After seven years of continuous research and development, we completed the Coupler device and released samples that showed 100 percent success, says CEO and founder of the company, Dr. Nandoun Abeysekera[1] |  |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |